ADUS
Price
$125.49Alerts
Change
-$0.80 (-0.63%)
Updated
Nov 11 closing price
Capitalization
2.32B
110 days until earnings call
Intraday BUY SELL Signals
CON
Price
$43.45Alerts
Change
+$0.78 (+1.83%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
5.38B
Intraday BUY SELL Signals
Interact to see
Advertisement

ADUS vs CON

ADUS vs CON Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADUS vs. CON commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a StrongBuy and CON is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADUS with price predictions
Nov 10, 2026

ADUS in upward trend: price rose above 50-day moving average on October 20, 2026

ADUS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 41 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ADUS as a result. In 62 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for ADUS just turned positive on October 08, 2026. Looking at past instances where ADUS's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.

The 10-day moving average for ADUS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.

Following a +1.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 202 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

The Aroon Indicator entered an Uptrend today. In 142 of 218 cases where ADUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for ADUS moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 18 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 64 cases where ADUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

ADUS broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.022) is normal, around the industry mean (204.532). P/E Ratio (21.433) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.483) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for CON with price predictions
Nov 10, 2026

CON in +1.07% Uptrend, rising for three consecutive days on November 10, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CON advanced for three days, in 100 of 135 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 54 of 87 cases where CON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Bearish Trend Analysis

The 10-day RSI Indicator for CON moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 12 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 15 of 27 cases where CON's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

CON broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.285) is normal, around the industry mean (204.532). P/E Ratio (27.239) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.006) settles around the average of (0.154) among similar stocks. P/S Ratio (2.035) is also within normal values, averaging (2.688).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADUS: Fundamental Ratings
ADUS
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
72
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADUSCON
RSI
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
61%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 8 days ago
65%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 9 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
62%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ADUS: $126.29 vs. CON: $42.67)
Brand notoriety: ADUS and CON are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ADUS: 102% vs. CON: 65%
Market capitalization -- ADUS: $2.32B vs. CON: $5.38B
ADUS [@Hospital/Nursing Management] is valued at $2.32B. CON’s [@Hospital/Nursing Management] market capitalization is $5.38B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADUS’s FA Score shows that 0 FA rating(s) are green while CON’s FA Score has 2 green FA rating(s).

  • ADUS’s FA Score: 0 green, 5 red.
  • CON’s FA Score: 2 green, 3 red.
According to our system of comparison, CON is a better buy in the long-term than ADUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADUS’s TA Score shows that 6 TA indicator(s) are bullish while CON’s TA Score has 2 bullish TA indicator(s).

  • ADUS’s TA Score: 6 bullish, 4 bearish.
  • CON’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ADUS is a better buy in the short-term than CON.

Price Growth

ADUS (@Hospital/Nursing Management) experienced а -0.21% price change this week, while CON (@Hospital/Nursing Management) price change was +6.28% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.65%. For the same industry, the average monthly price growth was +0.49%, and the average quarterly price growth was +11.07%.

Reported Earning Dates

ADUS is expected to report earnings on Mar 01, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-5.65% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ADUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with PNTG. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then PNTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADUS
1D Price
Change %
ADUS100%
+3.16%
PNTG - ADUS
41%
Loosely correlated
+1.32%
HCSG - ADUS
39%
Loosely correlated
+2.10%
NHC - ADUS
36%
Loosely correlated
-0.56%
ENSG - ADUS
36%
Loosely correlated
+1.64%
CON - ADUS
32%
Poorly correlated
+0.64%
More

CON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CON has been loosely correlated with PNTG. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CON jumps, then PNTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CON
1D Price
Change %
CON100%
+0.64%
PNTG - CON
45%
Loosely correlated
+1.32%
UHS - CON
40%
Loosely correlated
-0.89%
AVAH - CON
38%
Loosely correlated
-0.08%
THC - CON
38%
Loosely correlated
+0.44%
HCSG - CON
36%
Loosely correlated
+2.10%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBDC26.610.03
+0.11%
Putnam BDC Income ETF (PBDC)
XLUX24.12-0.05
-0.21%
Corgi U.S. Utilities 2x Daily ETF (XLUX)
VSDB74.81-0.24
-0.32%
Vanguard Short Duration Bond ETF (VSDB)
DRGN28.32-0.17
-0.61%
Themes China Generative Artificial Intelligence ETF (DRGN)
IBGA23.08-0.26
-1.12%
iShares iBonds Dec 2044 Term Treasury ETF (IBGA)